Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication (Q28749406)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 7 September 2010)

Language	Label	Description	Also known as
English	Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication	scientific article (publication date: 7 September 2010)

Statements

scholarly article

0 references

Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication (English)

0 references

anti-retroviral agent

0 references

human pregnancy

1 reference

based on heuristic

inferred from title

pregnant person

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Mirjam-Colette Kempf

2

object named as

Mirjam-Colette Kempf

0 references

author name string

Erika Aaron

1

0 references

Shannon Criniti

3

0 references

Ellen Tedaldi

4

0 references

Ed Gracely

5

0 references

Amy Warriner

6

0 references

Ritu Kumar

7

0 references

Laura H Bachmann

8

0 references

language of work or name

0 references

publication date

7 September 2010

0 references

0 references

5

0 references

9

0 references

e12617

0 references

copyright license

Creative Commons Attribution 4.0 International

7 September 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Risk for immune-mediated liver reactions by nevirapine revisited.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Efficacy and Durability of Nevirapine in Antiretroviral-Experienced Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Sex differences in nevirapine rash

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

20 June 2018

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Does gender and nevirapine (NVP) influence abnormal liver functions in HIV disease?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Hepatotoxicity associated with nevirapine use.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Grade 4 Events Are as Important as AIDS Events in the Era of HAART

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Nevirapine toxicity in a cohort of HIV-1-infected pregnant women

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012617

21 January 2018

Are adverse events of nevirapine and efavirenz related to plasma concentrations?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935387

27 November 2018

Hepatotoxicity of antiretrovirals: incidence, mechanisms and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/20838641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20838641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0012617

0 references

2010PLoSO...512617A

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28749406&oldid=1947161822"